Last update 01 Nov 2024

Bcr-Abl T315I x NRAS

Basic Info

Related Targets
Bcr-Abl T315INRAS

Related

1
Drugs associated with Bcr-Abl T315I x NRAS
GNF-7
Target
Bcr-Abl T315I x NRAS
Mechanism
Bcr-Abl T315I inhibitors [+1]
Active Org.
Novartis Institutes for Biomedical Research, Inc.Novartis Institutes for Biomedical Research, Inc. [+1]
Originator Org.
ActivX Biosciences, Inc.
Active Indication
Neoplasms
Inactive Indication
acute leukemia
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with Bcr-Abl T315I x NRAS
Login to view more data
100 Translational Medicine associated with Bcr-Abl T315I x NRAS
Login to view more data
0 Patents (Medical) associated with Bcr-Abl T315I x NRAS
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free